OI Therapy Raised BMD, Not Fracture Benefit - Top-Institutions - MDSpire

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

By
Andrea Surnit
June 5, 2026
7 min

Conexiant

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

#1

Aarhus University Hospital

Aarhus, Denmark
Key Differentiators
- Endocrinology
#2

The Jikei University School of Medicine

Tokyo, Japan
Key Differentiators
- Endocrinology
#3

University of Toronto

Toronto, Ontario
Key Differentiators
- Endocrinology
#4

Ethics Commission Northwest Switzerland

Basel, Switzerland
Key Differentiators
- Ethics
#5

Look AHEAD: Action for Health in Diabetes

Multiple Locations, USA
Key Differentiators
- Diabetes